Secular Growth

230 tickers in this investment thesis
Ranks this page's recent reports by score.
Edgewise Therapeutics, Inc.
EWTX·Healthcare
A ★★★★Buy
Current$40.84
Target$55.00
Return+34.7%
Jul 29, 2026

An impregnable $1.53B cash floor and a structurally superior cardiovascular asset provide massive upside convexity against peers, though absolute reliance on Phase 3 clinical success against entrenched incumbents remains the core risk.

Score
90
COPT Defense Properties
CDP·Real Estate
A ★★★★Buy
Current$38.03
Target$44.02
Return+15.8%
Jul 29, 2026

COPT Defense offers an impenetrable real estate monopoly deeply embedded in the U.S. defense apparatus, positioned for structural growth through cyber and intelligence spending, though extreme reliance on federal budgets poses long-term concentration risk.

Score
88
MaxLinear, Inc.
MXL·Technology
B ★★★Hold
Current$64.86
Target$99.32
Return+53.1%
Jul 29, 2026

MaxLinear offers explosive hyper-growth potential as a primary challenger in the AI optical interconnect space with its 800G/1.6T DSPs, but a fragile balance sheet and the catastrophic threat of the Silicon Motion arbitration demand immense caution.

Score
76
Global-E Online Ltd.
GLBE·Consumer Discretionary
A ★★★★Buy
Current$37.76
Target$70.00
Return+85.4%
Jul 29, 2026

Global-e Online dominates cross-border e-commerce enablement with robust 40% GMV growth and expanding EBITDA margins, bolstered by strategic M&A and a formidable $500 million share buyback program.

Score
92
First Industrial Realty Trust, Inc.
FR·Real Estate
A ★★★★Buy
Current$66.99
Target$78.00
Return+16.4%
Jul 29, 2026

First Industrial offers a premier, supply-constrained logistics portfolio generating massive 39% rent spreads and hidden data center land value, though near-term occupancy dips require careful execution of its Q4 development lease-up pipeline.

Score
88
Baker Hughes Company
BKR·Energy
B ★★★Hold
Current$60.59
Target$70.60
Return+16.5%
Jul 29, 2026

Baker Hughes offers unparalleled exposure to the secular LNG and AI data center power supercycle through its dominant IET segment, but heavy acquisition debt and Middle East margin pressures demand near-term patience.

Score
79
Veradermics, Incorporated
MANE·Healthcare
B ★★★Hold
Current$109.51
Target$163.50
Return+49.3%
Jul 29, 2026

Veradermics controls a revolutionary, multi-billion-dollar dermatology asset funded completely through 2030, but extreme reliance on flawless Phase 3 data and potential FDA cardiac scrutiny cap immediate near-term upside.

Score
75
Caris Life Sciences, Inc.
CAI·Healthcare
S ★★★★★Strong Buy
Current$15.56
Target$26.51
Return+70.4%
Jul 29, 2026

Caris Life Sciences pairs explosive 79% revenue growth and dominant molecular profiling margins with a highly compelling valuation, establishing a definitive AI-driven moat in precision oncology.

Score
99
Kymera Therapeutics, Inc.
KYMR·Healthcare
B ★★★Hold
Current$110.57
Target$140.00
Return+26.6%
Jul 29, 2026

Kymera offers a revolutionary opportunity to capture tens of billions in immunology market share by replacing injectable biologics with oral degraders, though the current premium valuation leaves no margin for error in its upcoming Phase 2b clinical trials.

Score
79
Expand Energy Corporation
EXE·Energy
A ★★★★Buy
Current$91.52
Target$128.00
Return+39.9%
Jul 28, 2026

Expand Energy offers a compelling valuation gap backed by unmatched scale in US natural gas production, fortified by its transformation into an integrated marketer and long-term tailwinds from AI data center power demand and LNG export capacity expansion.

Score
89
DTE Energy Company
DTE·Utilities
B ★★★Hold
Current$148.45
Target$161.70
Return+8.9%
Jul 28, 2026

DTE Energy offers a massive data-center-driven load growth pipeline and a reliable 3.1% dividend yield, offset by elevated valuation multiples, heavy capital expenditure reliance, and pending regulatory rate-case risks.

Score
75
CenterPoint Energy, Inc.
CNP·Utilities
B ★★★Hold
Current$44.56
Target$48.00
Return+7.7%
Jul 28, 2026

The unprecedented 12.2 GW data center load guarantees multi-decade rate base compounding, but the towering 26x P/E multiple demands flawless execution amidst severe interest rate and extreme weather vulnerabilities.

Score
75
Five Below, Inc.
FIVE·Consumer Discretionary
S ★★★★★Strong Buy
Current$203.19
Target$262.45
Return+29.2%
Jul 28, 2026

Five Below is a peerless, debt-free youth retail compounder executing a massive 3,500-store expansion and margin-accretive up-pricing strategy, offering profound undervalued hyper-growth despite remaining exposed to unpredictable U.S.-China tariff escalations.

Score
96
Progyny, Inc.
PGNY·Healthcare
B ★★★Hold
Current$31.19
Target$38.00
Return+21.8%
Jul 27, 2026

A highly profitable, cash-printing leader in fertility benefits trading at deeply discounted multiples, offset by fears of intensifying enterprise competition and the optical fallout of a mega-client departure.

Score
83
Calix, Inc.
CALX·Technology
B ★★★Hold
Current$36.00
Target$55.00
Return+52.8%
Jul 27, 2026

Calix presents a massive margin-expansion opportunity driven by its AI-native software transition and $1B+ BEAD funding tailwinds, offset by severe near-term margin compression from elevated memory component costs.

Score
81
On Holding AG
ONON·Consumer Discretionary
A ★★★★Buy
Current$35.82
Target$52.20
Return+45.7%
Jul 27, 2026

On Holding pairs unmatched premium pricing power (64%+ margins) and explosive APAC growth against severe valuation hurdles and escalating competition from industry titans.

Score
86
Dycom Industries, Inc.
DY·Industrials
B ★★★Hold
Current$429.81
Target$515.00
Return+19.8%
Jul 27, 2026

Dycom represents the ultimate 'picks and shovels' play on the generational AI data center and FTTH super-cycles, though its demanding valuation multiple and intense reliance on AT&T's capex budget warrant strict entry-price discipline.

Score
80
Futu Holdings Limited
FUTU·Financials
B ★★★Hold
Current$99.36
Target$135.00
Return+35.9%
Jul 27, 2026

The core bull case relies on Moomoo's highly profitable, scalable international expansion and deep valuation discount, counterbalanced by the severe concern of a forced mainland Chinese market exit and pending securities fraud litigation.

Score
76
NextEra Energy, Inc.
NEE·Utilities
A ★★★★Buy
Current$89.78
Target$105.00
Return+16.9%
Jul 27, 2026

NextEra Energy dominates the clean electrification supercycle via its unrivaled 35.1 GW renewable backlog and explosive data center power demand, though investors must meticulously navigate the execution risks of the Dominion mega-merger and holding company leverage.

Score
87
Celestica Inc.
CLS·Technology
B ★★★Hold
Current$305.28
Target$406.00
Return+33.0%
Jul 27, 2026

Celestica offers structural growth driven by the AI hyperscaler supercycle but carries severe valuation and concentration risks.

Score
78